Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 28 | 6 | 139 | 116 |
| Receivables | 8 | 29 | 13 | 260 | 389 |
| TOTAL | $163 | $241 | $57 | $913 | $995 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 15 | 28 |
| TOTAL | $N/A | $N/A | $N/A | $15 | $28 |
| Total Assets | $163 | $241 | $57 | $927 | $1,023 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 595 | N/A | N/A | 190 | 374 |
| Accounts payable and accrued liabilities | 4,333 | 4,646 | 4,898 | 2,784 | 3,865 |
| Other current liabilities | 505 | 411 | 510 | 175 | 136 |
| TOTAL | $5,469 | $5,057 | $5,469 | $3,308 | $4,375 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36 | 61 | N/A | 28 | N/A |
| Other Non-Current Liabilities | 74 | 830 | 626 | 690 | 99 |
| TOTAL | $36 | $884 | $353 | $718 | $99 |
| Total Liabilities | $5,505 | $5,941 | $5,822 | $4,026 | $4,474 |
| Shareholders' Equity | |||||
| Common Shares | 58,046 | 58,115 | 58,649 | 60,195 | 47,645 |
| Retained earnings | -86,041 | -85,237 | -85,845 | -82,382 | -68,104 |
| Other shareholders' equity | 22,654 | 21,421 | 21,432 | 19,088 | 17,008 |
| TOTAL | $-5,341 | $-5,700 | $-5,765 | $-3,099 | $-3,451 |
| Total Liabilities And Equity | $163 | $241 | $57 | $927 | $1,022 |